For Referring Doctors

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Each quarter,  The Leading Edge newsletter highlights new topics to give our referring physicians the latest news on leading-edge therapies that SCCA physicians are offering.

2014  |  2013  |  2012  |  2011  |  2010  |  2009  |  2008

Issue 26

Date: October 29, 2012
Fall 2012
In this issue we present
  • Proton Therapy for Prostate Cancer: New Opportunities and Challenges 
  • Esophageal Cancer: Early Diagnosis and Specialized Surgeries Can Improve Outcomes
  • Esophageal Cancer: A Moving Target, an Opportunity
  • Robotic Surgery for Endometrial Cancer--And Survivors' Obesity -Related Risks
  • Non-Invasive Screening Test Could Replace Colonoscopy
  • Pretargeted Radioimmunotherapy: a New, Improved Way to Treat Leukemia

Additionally, we welcome Gabriela Chiorean, MD, an associate professor of medicine at the University of Washington School of Medicine and an associate member at Fred Hutchinson Cancer Research Center who specializes in treating pancreatic, gastrointestinal, and hepatobiliary cancers at Seattle Cancer Care Alliance.

Issue 25

Date: August 15, 2012

In this issue we present the pros and cons of PSA testing for patients, SCCA’s Liver Tumor Clinic, treatment updates for high-risk, localized prostate cancer, new studies for using transplantation to treat Crohn’s Disease, a new multi-center trial comparing haploidentical and cord blood transplants, as well as a new trial for engineered T cells to treat leukemia and lymphoma.

Additionally, we welcome Alessandro Fichera, MD, to the new director of the University of Washington Medical Center Colorectal Surgery. 

Issue 24

Date: June 12, 2012

In this issue we present some promising new immunotherapy studies,  low-dose CT Screening for lung cancer, a new multi-center trial opening soon for haploidentical and cord blood transplants, non-chemotherapy treatment for follicular lymphoma, a provider profile on Edward N. Libby, MD, as well as information on the most informative CME of the year.

Issue 23

Date: March 01, 2012
Winter 2012

In this issue we present a ground-breaking gene therapy study for Fanconi anemia in adults, a new genomic test for ovarian cancer, new treatment for patients with colon cancer metastases to the liver. Additionally, we spotlight one of our national leaders in cardiothoracic surgery, Dr. Michael Mulligan.


2014  |  2013  |  2012  |  2011  |  2010  |  2009  |  2008